搜索优化
English
搜索
图片
视频
地图
资讯
购物
Copilot
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
on MSN
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
3 天
'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
9 天
on MSN
Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
3 天
What you need to know before considering weight loss jabs
Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...
ConsumerAffairs
6 小时
Could there be a ‘vaccine’ that prevents weight gain?
GLP-1 drugs like Ozempic became so popular as weight loss drugs that there was a mid-year shortage. These drugs are also ...
i
2 天
How NHS weight-loss jab delays triggered new private clinic boom
More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...
krcgtv.com
7 天
Weight loss options to help New Year's resolutions include GLP-1 injections
The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for ...
7 天
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈